Prevalence and risks of chronic airway obstruction: A population cohort study in Taiwan

Chest

Volumn 131, Issue 3, 2007, Pages 705-710

  Wang, Yu Chun ^a   Lin, Jia Ming ^a   Li, Chung Yi ^b   Lee, Long Teng ^c   Guo, Yue Liang ^a   Sung, Fung Chang ^d  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Chronic airway obstructions; Comorbidity; Population cohort; Universal health insurance

Indexed keywords

ADULT; AGE; AGED; ARTHROPATHY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; FEMALE; GENDER; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; INCIDENCE; INFLUENZA; INTERNATIONAL CLASSIFICATION OF DISEASES; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATIENT CARE; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; REIMBURSEMENT; RISK FACTOR; SKIN DISEASE; TAIWAN; URBANIZATION;

EID: 33947433266     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.06-1829     Document Type: Article

References (34)

1. Burney P, Suissa S, Soriano JB, et al. The pharmacoepidemiology of COPD: recent advances and methodological discussion. Eur Respir J Suppl 2003; 43:1s-44s
2. Viegi G, Pedreschi M, Pistelli F, et al. Prevalence of airways obstruction in a general population: European Respiratory Society vs American Thoracic Society definition. Chest 2000; 117:339S-345S
3. Plan and operation of Third National Health and Nutrition Examination Survey, 1988-94: Series 1; Programs and collection procedures. Vital Health Stat 1 1994; 32:1-407
4. McKnight J, Scott A, Menzies D, et al. A cohort study showed that health insurance databases were accurate to distinguish chronic obstructive pulmonary disease from asthma and classify disease severity. J Clin Epidemiol 2005; 58:206-208
5. Cerveri I, Accordini S, Verlato G, et al. Variations in the prevalence across countries of chronic bronchitis and smoking habits in young adults. Eur Respir J 2001; 18:85-92
6. Mannino DM, Gagnon RC, Petty TL, et al. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000; 160:1683-1689
7. Zielinski J, Bednarek M. Early detection of COPD in a high-risk population using spirometric screening. Chest 2001; 119:731-736
8. Burrows B, Earle RH. Prediction of survival in patients with chronic airway obstruction. Am Rev Respir Dis 1969; 99:865-871
9. Connors AF Jr, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease: the SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med 1996; 154:959-967
10. Fuso L, Incalzi RA, Pistelli R, et al. Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. Am J Med 1995; 98:272-277
11. Incalzi R, Fuso L, De Rosa M, et al. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J 1997; 10:2794-2800
12. Traver GA, Cline MG, Burrows B. Predictors of mortality in chronic obstructive pulmonary disease: a 15-year follow-up study. Am Rev Respir Dis 1979; 119:895-902
13. Anthonisen NR. Prognosis in chronic obstructive pulmonary disease: results from multicenter clinical trials. Am Rev Respir Dis 1989; 140:S95-S99
14. Rana JS, Mittleman MA, Sheikh J, et al. Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women. Diabetes Care 2004; 27:2478-2484
15. Fouad MN, Mayo CP, Funkhouser EM, et al. Comorbidity independently predicted death in older prostate cancer patients, more of whom died with than from their disease. J Clin Epidemiol 2004; 57:721-729
16. Tan WC, Xiang X, Qiu D, et al. Epidemiology of respiratory viruses in patients hospitalized with near-fatal asthma, acute exacerbations of asthma, or chronic obstructive pulmonary disease. Am J Med 2003; 115:272-277
17. Summaries for patients. The effects of a smoking cessation program on long-term survival in smokers with mild lung disease. Ann Intern Med 2005; 142:112
18. Schoening SK. Issues and challenges for managed care in the treatment of asthma and chronic obstructive pulmonary disease. Am J Manag Care 2004; 10:S158-163
19. Weng HC. Impacts of a government-sponsored outpatient-based disease management program for patients with asthma: a preliminary analysis of national data from Taiwan. Dis Manag 2005; 8:48-58
20. National Health Insurance Profile [in Chinese]: Taipei: Bureau of National Health Insurance, Department of Health, Executive Yuan, Republic of China, 2001
21. Lundback B, Gulsvik A, Albers M, et al. Epidemiological aspects and early detection of chronic obstructive airway diseases in the elderly. Eur Respir J Suppl 2003; 40:3s-9s
22. Mannino DM. Chronic obstructive pulmonary disease: definition and epidemiology. Respir Care 2003; 48:1185-1191; discussion 1191-1193
23. Donaldson GC, Seemungal TA, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002; 57:847-852
24. Donaldson GC, Seemungal TA, Patel IS, et al. Longitudinal changes in the nature, severity and frequency of COPD exacerbations. Eur Respir J 2003; 22:931-936
25. van Schayck CP, Smit HA. The prevalence of asthma in children: a reversing trend. Eur Respir J 2005; 26:647-650
26. Rennard S, Decramer M, Calverley PM, et al. Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J 2002; 20:799-805
27. Cheng SH, Chiang TL. The effect of universal health insurance on health care utilization in Taiwan: results from a natural experiment. JAMA 1997; 278:89-93
28. Cheh YH, Liou SH, Chou CC, et al. Influenza and pneumococcal vaccination of the elderly in Taiwan. Vaccine 2004; 22:2806-2811
29. Wang CS, Wang ST, Lai CT, et al. Reducing major cause-specific hospitalization rates and shortening hospital stays after influenza vaccination. Clin Infect Dis 2004; 39:1604-1610
30. Wang ST, Lee LT, Chen LS, et al. Economic evaluation of vaccination against influenza in the elderly: an experience from a population-based influenza vaccination program in Taiwan. Vaccine 2005; 23:1973-1980
31. Bhattarai MD. Asthma mistaken for chronic obstructive pulmonary disease. Lancet 2003; 361:1914-1915
32. Bleecker ER. Similarities and differences in asthma and COPD: the Dutch hypothesis. Chest 2004; 126:93S-95S; discussion 159S-161S
33. Hansen EF, Phanareth K, Laursen LC, et al. Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159:1267-1271
34. Ulrik CS, Backer V. Nonreversible airflow obstruction in life-long nonsmokers with moderate to severe asthma. Eur Respir J 1999; 14:892-896